We are already seeing the positive impact of these efforts, based on exceptional enrollment in the pivotal SOL-1 AXPAXLI study for wet AMD, coupled with plans for a new SOL-R repeat dosing study and ...
WASHINGTON, D.C. (Sept. 1, 2020) – Nationwide and Sol Systems today announced their joint venture, Helios Infrastructure (Helios), completed the purchase of four operating Texas solar projects ...
BEDFORD, Mass., June 13, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”, the “Company”), a biopharmaceutical company committed to enhancing people’s vision and quality of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback